• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study.

作者信息

Riva Nicoletta, Di Minno Matteo N D, Mumoli Nicola, Pomero Fulvio, Franchini Massimo, Bellesini Marta, Lupoli Roberta, Sabatini Silvia, Borretta Valentina, Bonfanti Carlo, Ageno Walter, Dentali Francesco

机构信息

Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy

Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy Unit of Cell and Molecular Biology in Cardiovascular Diseases, Centro Cardiologico Monzino, IRCCS, Milan, Italy.

出版信息

Haematologica. 2015 Aug;100(8):e295-8. doi: 10.3324/haematol.2015.127183. Epub 2015 Apr 17.

DOI:10.3324/haematol.2015.127183
PMID:25887499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5004428/
Abstract
摘要

相似文献

1
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study.维生素K拮抗剂治疗静脉血栓栓塞期间使用他汀类药物与出血风险：一项多中心回顾性队列研究
Haematologica. 2015 Aug;100(8):e295-8. doi: 10.3324/haematol.2015.127183. Epub 2015 Apr 17.
2
Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism.阿托伐他汀对貌似健康个体及既往有静脉血栓栓塞症患者血浆纤维蛋白凝块特性的影响。
Thromb Haemost. 2012 Jun;107(6):1180-2. doi: 10.1160/TH11-12-0851. Epub 2012 Feb 28.
3
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.瑞舒伐他汀可降低静脉血栓栓塞患者的凝血酶生成潜能：一项随机对照试验。
J Thromb Haemost. 2019 Feb;17(2):319-328. doi: 10.1111/jth.14364. Epub 2019 Feb 3.
4
Statins and prevention of venous thromboembolism: Myth or reality?他汀类药物与静脉血栓栓塞的预防：神话还是现实？
Arch Cardiovasc Dis. 2016 Mar;109(3):216-22. doi: 10.1016/j.acvd.2015.11.007. Epub 2016 Jan 14.
5
Tinzaparin and VKA use in patients with cancer associated venous thromboembolism: a retrospective cohort study.癌症相关静脉血栓栓塞患者中使用替扎肝素和维生素K拮抗剂：一项回顾性队列研究。
Thromb Res. 2015 Jan;135(1):78-83. doi: 10.1016/j.thromres.2014.10.030. Epub 2014 Nov 6.
6
[Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].[抗维生素K治疗期间的出血。发病率、危险因素及与新型口服抗凝剂的比较]
Medicina (B Aires). 2012;72(5):419-24.
7
Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients.14777 例房颤和静脉血栓栓塞患者极度过度抗凝后华法林治疗的长期质量和临床结局。
Thromb Haemost. 2015 Apr;113(4):881-90. doi: 10.1160/TH14-06-0537. Epub 2014 Dec 18.
8
Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review.预测静脉血栓栓塞症患者的抗凝相关出血：临床导向的综述。
Eur Respir J. 2015 Jan;45(1):201-10. doi: 10.1183/09031936.00040714. Epub 2014 Aug 7.
9
Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.非维生素K拮抗剂口服抗凝药在静脉血栓栓塞管理中的获益-风险概况
Thromb Haemost. 2015 Feb;113(2):231-46. doi: 10.1160/TH14-06-0484. Epub 2014 Oct 16.
10
Long-term treatment of venous thromboembolism with tinzaparin compared to vitamin K antagonists: a meta-analysis of 5 randomized trials in non-cancer and cancer patients.与维生素 K 拮抗剂相比，用亭扎肝素进行静脉血栓栓塞的长期治疗：5 项非癌症和癌症患者随机试验的荟萃分析。
Thromb Res. 2012 Dec;130(6):853-8. doi: 10.1016/j.thromres.2012.08.290. Epub 2012 Aug 28.

引用本文的文献

1
Statins for the primary prevention of venous thromboembolism.他汀类药物用于预防静脉血栓栓塞症的一级预防。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD014769. doi: 10.1002/14651858.CD014769.pub2.
2
Assessment of bleeding events in patients receiving DOACs with or without statins to treat venous thromboembolism: insights from the RIETE registry.评估接受 DOACs 治疗静脉血栓栓塞症的患者中有或无他汀类药物的出血事件：来自 RIETE 登记处的见解。
BMJ Open. 2024 Oct 22;14(10):e085401. doi: 10.1136/bmjopen-2024-085401.
3
Tissue Engineering and Targeted Drug Delivery in Cardiovascular Disease: The Role of Polymer Nanocarrier for Statin Therapy.心血管疾病中的组织工程与靶向药物递送：聚合物纳米载体在他汀类药物治疗中的作用
Biomedicines. 2023 Mar 6;11(3):798. doi: 10.3390/biomedicines11030798.
4
Shrinking Weibel-Palade bodies prevents high platelet recruitment in assays using thrombotic thrombocytopenic purpura plasma.在使用血栓性血小板减少性紫癜血浆的检测中，缩小魏尔-帕拉德小体可防止大量血小板募集。
Res Pract Thromb Haemost. 2021 Dec 7;5(8):e12626. doi: 10.1002/rth2.12626. eCollection 2021 Dec.
5
Vitamin K Intake in Chronic Stroke: Implications for Dietary Recommendations.慢性中风患者的维生素 K 摄入量：对饮食建议的影响。
Nutrients. 2020 Oct 6;12(10):3059. doi: 10.3390/nu12103059.

本文引用的文献

1
Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy.他汀类药物的使用对接受利伐沙班或标准抗凝治疗的患者复发性静脉血栓栓塞和大出血发生率的影响。
Thromb J. 2014 Nov 26;12:26. doi: 10.1186/1477-9560-12-26. eCollection 2014.
2
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.当代出血风险评分在静脉血栓栓塞症长期治疗中的预测价值不佳。一项多中心回顾性队列研究。
Thromb Haemost. 2014 Sep 2;112(3):511-21. doi: 10.1160/TH14-01-0081. Epub 2014 Jun 5.
3
Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study.他汀类药物的使用与静脉血栓栓塞复发：一项全国性队列研究和巢式病例对照研究。
J Thromb Haemost. 2014 Aug;12(8):1207-15. doi: 10.1111/jth.12604. Epub 2014 Jun 19.
4
Anticoagulant effects of statins and their clinical implications.他汀类药物的抗凝作用及其临床意义。
Thromb Haemost. 2014 Mar 3;111(3):392-400. doi: 10.1160/TH13-08-0720. Epub 2013 Nov 28.
5
Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study.他汀类药物治疗与复发性静脉血栓栓塞风险：一项全国性队列研究。
BMJ Open. 2013 Nov 7;3(11):e003135. doi: 10.1136/bmjopen-2013-003135.
6
Statin treatment and the risk of recurrent pulmonary embolism.他汀类药物治疗与复发性肺栓塞风险。
Eur Heart J. 2013 Jun;34(24):1800-6. doi: 10.1093/eurheartj/eht046. Epub 2013 Feb 8.
7
Statins for acute ischemic stroke.他汀类药物用于急性缺血性卒中
Cochrane Database Syst Rev. 2011 Aug 10(8):CD007551. doi: 10.1002/14651858.CD007551.pub2.
8
Missing covariate data in medical research: to impute is better than to ignore.医学研究中缺失的协变量数据：填补优于忽略。
J Clin Epidemiol. 2010 Jul;63(7):721-7. doi: 10.1016/j.jclinepi.2009.12.008. Epub 2010 Mar 24.
9
Statins, fibrates, and venous thromboembolism: a meta-analysis.他汀类药物、贝特类药物和静脉血栓栓塞症：一项荟萃分析。
Eur Heart J. 2010 May;31(10):1248-56. doi: 10.1093/eurheartj/ehp556. Epub 2009 Dec 22.
10
Unraveling pleiotropic effects of statins: bit by bit, a slow case with perspective.解析他汀类药物的多效性：一点一点地，这是一个有前景的缓慢进程。
Circ Res. 2008 Aug 15;103(4):334-6. doi: 10.1161/CIRCRESAHA.108.182220.